The potential applications of Pt complexes depend on the coordinating auxiliary ligand(s) and ancillary/leaving ligand(s) attached to the metal. Pt(II) complexes bearing ONS-donor salicylaldimine auxiliary ligand with general formula LPtX, (L = ONS-donor salicylaldimine ligand) with functionalized ancillary ligand X (X = Cl, Br, I and OAc) (C1a-C4a and C1b-C4b) were synthesized using a well-established method. All these complexes were characterized in solution and in solid state using multiple analytical techniques. The effect of ancillary ligand modification was studied on multiple features including crystallization, metal aquation, fluorescence, lipophilicity, electrochemistry and anticancer activities of these complexes. Depending on the ancillary ligands, from single crystal X-ray analysis different structural features in solid state or arrangement in crystal packing were observed. The ancillary ligand (Cl, Br, I, and OAc) hydration in DMSO‑d6/D2O mixture to form cationic [L-Pt-H2O]+ was analyzed by time dependent 1H NMR spectroscopy. The ancillary ligands also affected fluorescence of these complexes, a trend of decreasing emission with increasing atomic mass of the attached atom as ancillary ligand was observed. Lipophilicity (log P) of “a” series was measured as reference series and we found the order depending on the ancillary ligand in each complex as I > Br > OAc > Cl, showing C3a lipophilicity was the highest and C1a was the lowest. Finally, these complexes were checked for their anticancer effect and the IC50 was calculated using MTT assay. These complexes showed better anticancer effect as compared to cisplatin. The anticancer effect was not linear with the previously discussed properties showing the anticancer activity may depend on the sum of multiple structural parameters and also depend on the nature of cancer cells, so it was not conclusive using a single set of parameters to comply with the other.
Read full abstract